VibroSense Dynamics (VSD) Q3 24/25 earnings summary

Executive summary

• Net sales for Q3 2025 increased by 59% year-over-year to SEK 753,596, driven by sales and rentals of hand and foot instruments.

• Net loss after financial items improved to SEK -1,232,330 from SEK -2,180,334 year-over-year, reflecting higher sales and reduced operating costs.

• Solid equity ratio of 87.2% at quarter-end, up from 72.4% a year earlier.

• Key strategic events include a new distributor agreement in Singapore and Hong Kong, a European patent grant, and a partnership in Norway.

• Awaiting regulatory approval for VibroSense Meter II in China, expected by June 2025.

Financial highlights

• Net sales: SEK 753,596 (Q3 2024: SEK 473,533), up 59% year-over-year.

• Net loss after financial items: SEK -1,232,330 (Q3 2024: SEK -2,180,334).

• Operating expenses decreased by 12% year-over-year, mainly due to lower marketing and consulting costs.

• Cash and cash equivalents at March 31, 2025: SEK 8,833,263 (Q3 2024: SEK 5,223,134).

• Q3 cash flow: SEK -1,442,047 (Q3 2024: SEK -2,074,206).

Outlook and guidance

• Cautious optimism for continued growth, with focus on market expansion and scientific validation.

• Preparing for potential market entry in China pending regulatory approval.

• Ongoing efforts to strengthen clinical evidence and expand use in diabetes and oncology.